参考文献

1.Light RW.Clinical practice.Pleural effusion.N Engl J Med，2002，346：1971-1977.

2.施焕中.重视胸腔积液的基础和临床研究.中华结核呼吸杂志，2013，36：323-324.

3.Burrows CM，Mathews WC，Colt HG.Predicting survival in patients with recurrent symptomatic malignant pleural effusions：an assessment of the prognostic values of physiologic，morphologic，and quality of life measures of extent of disease.Chest，2000，117：73-78.

4.Roberts ME，Neville E，Berrisford RG，et al.Management of a malignant pleural effusion：British Thoracic Society Pleural Disease Guideline 2010.Thorax，2010，65（2）：ii32-40.

5.Salyer WR，Eggleston JC，Erozan YS.Efficacy of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neoplasm involving the pleura.Chest，1975，67：536-539.

6.Harris RJ，Kavuru MS，Rice TW，et al.The diagnostic and therapeutic utility of thoracoscopy.A review.Chest，1995，108：828-841.

7.童朝辉，王臻，王辰.内科胸腔镜技术及其临床应用.中华结核和呼吸杂志，2007，30：220-222.

8.Kim BS，Kim IJ，Kim SJ，et al.Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.Onkologie，2011，34：298-303.

9.Shi HZ，Liang QL，Jiang J，et al.Diagnostic value of carcinoembryonic antigen in malignant pleural effusion：a meta-analysis.Respirology，2008，13：518-527.

10.Liang QL，Shi HZ，Qin XJ，et al.Diagnostic accuracy of tumor markers for malignant pleural effusion：a metaanalysis.Thorax，2008，63：35-41.

11.Parulekar W，Di Primio G，Matzinger F，et al.Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions.Chest，2001，120：19-25.

12.Maskell NA，Lee YC，Gleeson FV，et al.Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size.Am J Respir Crit Care Med，2004，170：377-382.

13.Kolschmann S，Ballin A，Gillissen A.Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.Chest，2005，128：1431-1435.

14.Ferrer J，Montes JF，Villarino MA，et al.Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis.Chest，2002，122：1018-1027.

15.Diacon AH，Wyser C，Bolliger CT，et al.Prospective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions.Am J Respir Crit Care Med，2000，162：1445-1449.

16.Janssen JP，Collier G，Astoul P，et al.Safety of pleurodesis with talc poudrage in malignant pleural effusion：a prospective cohort study.Lancet，2007，369：1535-1539.

17.Danby CA，Adebonojo SA，Moritz DM.Video-assisted talc pleurodesis for malignant pleural effusions utilizing local anesthesia and I.V.sedation.Chest，1998，113：739-742.

18.Fysh ET，Waterer GW，Kendall PA，et al.Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion.Chest，2012，142：394-400.

19.Groth G，Gatzemeier U，Häussingen K，et al.Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo（pleural tube alone）.Ann Oncol，1991，2：213-215.

20.Janes SM，Rahman NM，Davies RJ，et al.Catheter-tract metastases associated with chronic indwelling pleural catheters.Chest，2007，131：1232-1234.

21.Davies CW，Traill ZC，Gleeson FV，et al.Intrapleural streptokinase in the management of malignant multiloculated pleural effusions.Chest，1999，115：729-733.

22.Fry WA，Khandekar JD.Parietal pleurectomy for malignant pleural effusion.Ann Surg Oncol，1995，2：160-164.

23.Waller DA，Morritt GN，Forty J.Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion.Chest，1995，107：1454-1456.